Document resource
Production of glucagon-like peptide-1 receptor (GLP-1) agonists such as semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) needs to be rapidly expanded and prices reduced, the World Health Organization (WHO) has said in new guidance.